Kyowa Kirin Co., Ltd. engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally. The company offers Ziftomenib, an oral menin inhibitor for the treatment of adult relapsed or refractory and acute myeloid leukemia with a nucelophosmin1 mutation; and Lumicef for the treatment of palmoplantar pustulosis. It also develops KHK4083/AMG 451 rocatinlimab, which is in Phase III clinical trial for the treatment of modera...
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 81 3 5205 7200
Address:
Otemachi Financial City Grand Cube, 1-9-2, Otemachi, Chiyoda, Japan
